GTC Biotherapeutics (fka GTCB)

[wjlknew]

<Dew, why do you think they avoid doing a RS?>

Your question was addressed to Dew, but in the interest of full disclosure:

A RS may temporarily cure a delisting concern, but that does not fix the underlying problem that caused the pps to slip in the first place ... in this case a cash flow problem. Moreover, a long awaited partnership with single digit upfront will only put a bandaid on the bleeding. This company had better get serious about obtaining a firm financial footing ... and a RS is not the way to start.

A RS is usually perceived as a desperate act by a desperate company and the pps will usually be punished as soon as the RS is made public.

A RS is almost always a losing proposition.